San Francisco Bay Area biotech stories.
Friday, August 10, 2012
Genentech's Lucentis approved for diabetic eye disease
Inc.'s eye drug
won FDA approval Friday to treat diabetic patients for a blinding disease
. South San Francisco-based Genentech, part of Swiss drug maker Roche, was
recommended last month by a Food and Drug Administration advisory panel
as a treatment for diabetic macular edema.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)